We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VIA Pharmaceuticals Inc (CE) | USOTC:VIAP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Delaware
( State or other jurisdiction of incorporation or organization ) |
33-0687976
( I.R.S. Employer Identification No. ) |
Copy to : | ||
Lawrence K. Cohen | Richard S. Meller, Esq. | |
President and Chief Executive Officer | Latham & Watkins LLP | |
VIA Pharmaceuticals, Inc. | Sears Tower, Suite 5800 | |
750 Battery Street, Suite 330 | 233 South Wacker Drive | |
San Francisco, CA 94111 | Chicago, Illinois 60606 | |
(415) 283-2200 | (312) 876-7700 |
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ | |||
(do not check if a smaller reporting company) |
VIA PHARMACEUTICALS, INC.
|
||||
By: | /s/ Lawrence K. Cohen | |||
Lawrence K. Cohen | ||||
President and Chief Executive Officer |
Signatures | Titles | Date | ||
|
||||
/s/ Lawrence K. Cohen
|
Director, President and Chief Executive Officer | December 30, 2010 | ||
|
||||
/s/ Douglass B. Given
|
Chairman of the Board of Directors | December 30, 2010 | ||
|
||||
|
||||
/s/ Mark N.K. Bagnall
|
Director | December 30, 2010 | ||
|
||||
|
||||
/s/ Fred B. Craves
|
Director | December 30, 2010 | ||
|
||||
/s/ David T. Howard
|
Director | December 30, 2010 | ||
|
||||
/s/ John R. Larson
|
Director | December 30, 2010 |
1 Year VIA Pharmaceuticals (CE) Chart |
1 Month VIA Pharmaceuticals (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions